<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on March 04, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04258891</url>
  </required_header>
  <id_info>
    <org_study_id>DYNAKT</org_study_id>
    <nct_id>NCT04258891</nct_id>
  </id_info>
  <brief_title>Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation</brief_title>
  <acronym>DYNAKT</acronym>
  <official_title>Development and Validation of a Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paris Translational Research Center for Organ Transplantation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Paris Translational Research Center for Organ Transplantation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of end stage renal disease (ESRD) is rapidly increasing, now affecting an&#xD;
      estimated 7.4 million people worldwide. Numerous parameters such as demographic, clinical and&#xD;
      functional factors drive the deterioration of the kidney, ultimately leading to ESRD.&#xD;
      Although some ESRD prediction models have been derived in the past years, none of these&#xD;
      models are dynamic: they do not integrate the repeated measurements recorded throughout&#xD;
      individuals' follow-up.&#xD;
&#xD;
      As highlighted in several studies, kidney function repeated measurements (i.e., trajectories)&#xD;
      are highly associated with graft survival after kidney transplantation. The investigators&#xD;
      made the hypothesis that these trajectories may bring relevant information in the context of&#xD;
      graft survival risk prediction model. Hence, combining these trajectories with standard graft&#xD;
      survival risk factors may enhance prediction performance. This could permit to derive a&#xD;
      robust tool that could be updated over time by continuously capturing patient' personal&#xD;
      evolution.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      850 million individuals suffer from chronic kidney disease (CKD), while diabetes, cancer, and&#xD;
      HIV/AIDS affect 422, 42, and 37 million individuals, respectively. End stage renal disease&#xD;
      (ESRD) hence places a heavy burden on health systems worldwide. Linked to that, the&#xD;
      kidney-disease-associated mortality rate worldwide has risen over the past decade, now&#xD;
      causing the death of 5 to 10 million individuals every year.&#xD;
&#xD;
      In kidney transplantation, numerous parameters such as demographic, clinical and functional&#xD;
      factors drive the deterioration of the kidney, sometimes leading to graft failure. Current&#xD;
      approaches for investigating the relationship between these factors and graft failure have&#xD;
      been limited by standard statistical approaches and by registries with an overall lack on&#xD;
      granular data, including infrequent kidney function measurements for a single patient and&#xD;
      convenience clinical samples. Identifying the determinants of graft failure with a dynamic&#xD;
      approach may bring an original perspective to the traditional graft survival risk prediction&#xD;
      model that are impeded by their reliance on low-granularity datasets, cross-sectional&#xD;
      parameters, and limited follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2004</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Allograft survival probability</measure>
    <time_frame>Up to 10 years after kidney transplantation</time_frame>
    <description>Allograft survival probability, calculated from a dynamic prediction system, based on clinical, histological, immunological and estimated glomerular filtration rate and proteinuria repeated measurements, assessed at the time of risk evaluation and that can be updated thereafter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Added prognostic value</measure>
    <time_frame>Up to 10 years after kidney transplantation</time_frame>
    <description>Added prognostic value of the dynamic prediction system over standard of care monitoring of kidney transplant recipients based on single value of estimated glomerular filtration rate and proteinuria</description>
  </secondary_outcome>
  <enrollment type="Anticipated">14000</enrollment>
  <condition>Kidney Transplant Failure</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Kidney recipients aged over 18 and of all sexes recruited from 2004 in European, North American and South American centers, who have estimated glomerular filtration rate and proteinuria follow-up and data from protocol and for cause biopsies for allograft survival assessment; Randomized controlled trials conducted over the past 20 years with available data on protocol biopsy within the first year and follow-up, clinical, biological and histological data.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Kidney recipients aged over 18 and of all sexes recruited from 2004 in European and North&#xD;
        American centers, who have estimated glomerular filtration rate and proteinuria repeated&#xD;
        measurements, data from protocol and for cause biopsies, as well as immunological,&#xD;
        clinical, functional parameters and survival data for allograft and patient survival&#xD;
        assessment. Additional kidney recipients from RCTs with longitudinal data including&#xD;
        baseline and follow-up clinical, functional, immunological and histological data.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Kidney recipients transplanted after 2004&#xD;
&#xD;
          -  Kidney recipients over 18 years of age&#xD;
&#xD;
          -  Kidney recipients with at least two estimated glomerular filtration rate and&#xD;
             proteinuria measurements after transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Combined transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Loupy, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Paris Translational Research Center for Organ Transplantation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgery, Johns Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Einstein College of Medicine, Renal Division Montefiore Medical Center, Kidney Transplantation Program</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unidad de Trasplante Renopáncreas, Centro de Educación Médica e Investigaciones Clínicas</name>
      <address>
        <city>Buenos Aires</city>
        <zip>4102</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidade Federal de São Paulo, Hospital do Rim, Escola Paulista de Medicina</name>
      <address>
        <city>São Paulo</city>
        <zip>04038-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Renal Transplantation Service</name>
      <address>
        <city>São Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Alemana de Santiago</name>
      <address>
        <city>Santiago</city>
        <zip>3204</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School od Medicine University of Zagreb</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Nephrology, Centre Hospitalier Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nephrology Dialysis Transplantation Department, University of Lorraine, Centre Hospitalier Universitaire de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Transplantation, Nephrology and Clinical Immunology, Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Nephrology and Organ Transplantation, Centre Hospitalier Universitaire Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bretonneau Hospital, Nephrology and Immunology Department</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Nephrology, Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Chile</country>
    <country>Croatia</country>
    <country>France</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.paristransplantgroup.org</url>
    <description>Paris Transplant Group Website</description>
  </link>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kidney Transplantation</keyword>
  <keyword>Graft survival</keyword>
  <keyword>Kidney function</keyword>
  <keyword>Prediction</keyword>
  <keyword>Dynamic</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

